BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9376259)

  • 1. The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation.
    Sharma R; Adam E; Schumacher U
    Br J Cancer; 1997; 76(8):1011-6. PubMed ID: 9376259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
    Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
    J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
    Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice.
    Schumacher U; Nehmann N; Adam E; Mukthar D; Slotki IN; Horny HP; Flens MJ; Schlegelberger B; Steinemann D
    Acta Histochem; 2012 Oct; 114(6):594-602. PubMed ID: 22154301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells.
    Aquino A; Prete SP; Guadagni F; Greiner JW; Giuliani A; Orlando L; Masci G; De Santis S; Bonmassar E; Graziani G
    Anticancer Res; 2000; 20(5B):3475-84. PubMed ID: 11131650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation.
    Melen-Mucha G; Balcerczak E; Mucha S; Panczyk M; Lipa S; Mirowski M
    Neoplasma; 2004; 51(4):319-24. PubMed ID: 15254665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell differentiation and chemotherapy influence p53 and Mdm2 immunoreactivity in human HT29 colon cancer cells grown in scid mice.
    Schumacher U; Adam E; Feldhaus S; Katoh M; Lane DP
    Cancer Lett; 2001 May; 166(2):215-21. PubMed ID: 11311495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate.
    Katoh M; Feldhaus S; Schnitzer T; Bauer S; Schumacher U
    Cancer Lett; 2004 Jul; 210(1):7-15. PubMed ID: 15172115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein expression in human tumours grown in severe combined immunodeficient mice.
    Katoh M; Koninkx J; Schumacher U
    Cancer Lett; 2000 Dec; 161(1):113-20. PubMed ID: 11078920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
    Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
    Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU.
    Kline CL; Shanmugavelandy SS; Kester M; Irby RB
    Cancer Biol Ther; 2009 Oct; 8(19):1831-7. PubMed ID: 19729995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
    Lim YJ; Rhee JC; Bae YM; Chun WJ
    World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic and pharmacodynamic study in vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy.
    McSheehy PM; Seymour MT; Ojugo AS; Rodrigues LM; Leach MO; Judson IR; Griffiths JR
    Eur J Cancer; 1997 Dec; 33(14):2418-27. PubMed ID: 9616292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolidinedithiocarbamate increases the therapeutic index of 5-fluorouracil in a mouse model.
    Bach SP; Chinery R; O'Dwyer ST; Potten CS; Coffey RJ; Watson AJ
    Gastroenterology; 2000 Jan; 118(1):81-9. PubMed ID: 10611156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.